Next, we performed survival analysis for TCGA-GBM data with MAGEH1 and MAGED1 expression, along with age, gender, molecular subtypes (38), IDH mutation status, and MGMT promoter methylation status (Table 4). Here, MAGED1 is linked to glioblastoma.